CLDN3 and dyskeratosis congenita: Although the abundance of E-cadherin and claudin-3 proteins has been studied indifferent clinical and experimental situations, to the best of our knowledge, theirtissue abundance has not yet been measured in experimental DC models of animalstreated with infliximab.